Dahlia Weiss

This inventor holds 11 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Nurix Therapeutics, Inc., Gilead Sciences, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dahlia Weiss. Retrieved from https://idiyas.com/inventor/dahlia-weiss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 9.1

ph-index = 4

Forward Citations = 32(Granted Patents)

Location History:

San Mateo, CA (US) (2022 - 2024)
San Francisco, CA (US) (2022 - 2024)

Company Filing History:

11 out of 22

Nurix Therapeutics, Inc.

patents

1 out of 946

Gilead Sciences, Inc.

patents

where one patent can have more than one assignee

Years Active: 2022-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12653809 - UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION (2026-06-16),

2. 12583862 - Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway (2026-03-24),

3. 12528814 - Bifunctional degraders of interleukin-1 receptor-associated kinases and therapeutic use thereof (2026-01-20),

4. 12234230 - Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof (2025-02-25),

5. 12049471 - Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof (2024-07-30),

6. 11951133 - 3-substituted piperidine compounds for Cbl-b inhibition, and use thereof (2024-04-09),

7. 11866442 - Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway (2024-01-09),

8. 11530229 - Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof (2022-12-20),

9. 11479556 - Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway (2022-10-25),

10. 11464802 - 3-substituted piperidine compounds for Cbl-b inhibition, and use thereof (2022-10-11),

11. 11401267 - Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof (2022-08-02),

Title: The Innovative Mind of Dahlia Weiss

Introduction: Dahlia Weiss, a pioneering inventor based in San Mateo, CA, is known for her groundbreaking contributions to the field of technology and innovation. As a woman in a male-dominated industry, she has defied stereotypes and carved out a name for herself through her ingenuity and creativity.

Latest Patents: Dahlia Weiss holds several patents in the realm of artificial intelligence and machine learning, with her most recent invention focusing on enhancing cybersecurity measures for large-scale enterprises. Her innovative solutions have garnered attention from tech giants worldwide.

Career Highlights: With a background in computer science and engineering, Dahlia Weiss began her career at a prominent tech company in Silicon Valley before venturing out to establish her own startup. Her entrepreneurial spirit and passion for pushing the boundaries of technology have led to numerous successes in the industry.

Collaborations: Throughout her career, Dahlia Weiss has collaborated with leading researchers, engineers, and developers to bring her ideas to life. Her ability to foster creative partnerships and think outside the box has been instrumental in her journey as an inventor.

Conclusion: Dahlia Weiss continues to inspire aspiring inventors and entrepreneurs with her innovative spirit and dedication to creating solutions that make a difference in the world. Her impact on the tech industry serves as a testament to the power of perseverance and creativity in driving meaningful change.

Profile summary based on public USPTO records.